The Institute of Molecular Diagnostics (INMODIA GmbH) offers those affected by possible vaccine damage and relatives of deceased persons after “Covid vaccination” the possibility of detecting the various components of RNA-based injections in different sample materials.

We concentrate on the visual detection of spike proteins in tissue samples (including tumour material), the measurement of the concentration of spike proteins in blood or cerebrospinal fluid (including immune cells) and the detection of “vaccine mRNA” and residual DNA (plasmid DNA). Our focus is on clarifying whether a sample contains spike proteins and whether these originate from a COVID-19 injection or from a natural infection.